DYN Kacepetan wutah bathi saben saham ing taun lumaku Dyne Therapeutics, Inc.

Simbol resmi perusahaan dyne-tx.com (DYN)

High volatility and operating expenses at Dyne Therapeutics, Inc. (DYN) necessitate a constant influx of investment, yet the brand is valued for its cutting-edge RNA platforms targeting muscle pathologies. GURU.Markets provides this chart, where the annual EPS growth rate demonstrates a trend and -10.20 becomes the new value for this metric. In the long term, patents for orphan drugs will enable industrial scaling with low production costs.

DYN: Wutah bathi saben saham ing taun lumaku Dyne Therapeutics, Inc. 04.07.2022 - 16.11.2026

Rincian metrik komprehensif lan analitis Dyne Corp (DYN)

- rega saham lan target rega konsensus:
Pambiji fundamental:Dyne Therapeutics, Inc.
Produk asli Dyne Pharma

This metric is calculated as the percentage deviation of current earnings per share from the same value last year, allowing the market to filter out noise and assess real business efficiency. For Dyne Therapeutics, Inc. (DYN), which implements robotic drug screening, the year-over-year earnings per share trend serves as an indicator of how laboratory automation optimizes costs and impacts bottom-line profitability.